BMJ  2003;326:1193-1196 (31 May), doi:10.1136/bmj.326.7400.1193

Education and debate

Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement

¹ 1312 21st Street NW, Washington, DC 20036, USA raymond.moynihan@verizon.net

The first 150 words of the full text of this article appear below.

If the American Medical Student Association has anything to do with it, relations between doctors and the pharmaceutical industry will soon look considerably different. Representing 30 000 students, interns, and residents throughout the United States, the association is running a campaign—PharmFree—calling for an end to gift giving, free lunches, sponsored education, and paid speaking.¹

Students are being urged to sign a PharmFree pledge to seek out unbiased sources of healthcare information and to take a recently revised Hippocratic oath, called a "model oath for the new physician," which includes the commitments: "I will make medical decisions... free from the influence of advertising or promotion. I will not accept money, gifts, or hospitality that will create a conflict of interest in my education, practice, teaching, or research."

The strange becomes familiar

The American Medical Student Association's campaign is inspired in part by the work of the New York based No Free Lunch, which . . . [Full text of this article]

Relationships with clinicians

Relationships with researchers

Moves towards disentanglement

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Food, flattery, and friendship

Jane Smith
BMJ 2003 326: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Epstein, R. A (2007). Influence of pharmaceutical funding on the conclusions of meta-analyses. BMJ 335: 1167-1167 [Full text]  
• Lubowitz, J. H., Appleby, D., Centeno, J. M., Woolf, S. K., Reid, J. B. III (2007). The Relationship Between the Outcome of Studies of Autologous Chondrocyte Implantation and the Presence of Commercial Funding. Am J Sports Med 35: 1809-1816 [Abstract] [Full text]  
• ADAMS, C. E., THARYAN, P., COUTINHO, E. S. F., STROUP, T. S. (2006). The schizophrenia drug-treatment paradox: pharmacological treatment based on best possible evidence may be hardest to practise in high-income countries. Br. J. Psychiatry 189: 391-392 [Abstract] [Full text]  
• Blumenthal, D. (2004). Doctors and Drug Companies. NEJM 351: 1885-1890 [Full text]  
• Rychetnik, L., Hawe, P., Waters, E., Barratt, A., Frommer, M. (2004). A glossary for evidence based public health. J. Epidemiol. Community Health 58: 538-545 [Abstract] [Full text]  
• Abbasi, K., Smith, R. (2003). No more free lunches. BMJ 326: 1155-1156 [Full text]